Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Roche Acquires Two Diagnostics Firms
by Ann M. Thayer
August 24, 2015
| A version of this story appeared in
Volume 93, Issue 33
Roche’s diagnostic division will pay up to $425 million to acquire California-based GeneWeave BioSciences. The privately held company develops clinical microbiology diagnostics around a technology it calls Smarticles. It is able to identify multi-drug-resistant organisms and assesses antibiotic susceptibility directly from clinical samples. Separately, Roche will also acquire Massachusetts-based Kapa Biosystems for an undisclosed amount. The firm uses protein engineering to generate, screen, and optimize enzymes for next-generation sequencing and polymerase chain reaction technology applications.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X